Innovative Technology Adoption Cortical Labs offers the groundbreaking CL1 biological computer, which integrates human neurons with silicon hardware, creating Synthetic Biological Intelligence. This pioneering technology presents a unique opportunity to advance research in neuroscience, medicine, and AI, appealing to research institutions and biotech companies seeking to leverage bioengineered computation.

Expanding Research Infrastructure With recent launches of scalable neural network server stacks and affordable cloud-based systems, Cortical Labs is enabling labs of varying sizes to access high-end biological computing. This opens the door for sales to educational institutions, startups, and established research centers looking to modernize their experimental capabilities.

Strategic Market Positioning As the world's first commercial biological computer, Cortical Labs is positioned at the forefront of the intersection of biotech and AI. Companies and organizations interested in innovative, energy-efficient AI solutions can see value in partnering or purchasing these systems to gain a competitive edge.

Funding and Revenue Potential With revenues ranging from one to ten million dollars and ongoing developments, there is a strong potential for growth and increased sales through targeted outreach to biotech, medical, and technology sectors that prioritize cutting-edge research tools and bioengineering solutions.

Partnership and Collaboration Opportunities Cortical Labs actively engages in research publications and industry events like MWC, highlighting opportunities for strategic collaborations and joint ventures with organizations interested in pioneering bio-AI research or commercializing biological computing applications.